Matches in SemOpenAlex for { <https://semopenalex.org/work/W2986155203> ?p ?o ?g. }
Showing items 1 to 71 of
71
with 100 items per page.
- W2986155203 abstract "Abstract OBJECTIVES Dogma suggests that for brain tumors, regions of enhancement on T1-weighted gadolinium contrast enhanced (T1Gd) magnetic resonance imaging (MRI) correlate with intravenously delivered drug distribution as enhancement indicates a compromised blood-brain barrier (BBB). However, poor response to intravenous therapies highlights the importance of the diffuse disease beyond enhancing regions. This study investigated whether imaging features can provide an accurate prediction of drug distribution. METHODS Eight brain tumor patients (7 gliomas and 1 metastatic adenocarcinoma) were included in this Phase 0 trial. Presurgery T1-weighted, T1Gd, T2-weighted gadolinium contrast enhanced (T2Gd), and T2-weighted Fluid Attenuated Inversion Recovery (T2FLAIR) MRIs were acquired. All images underwent bias correction using the N4 algorithm, standardization of intensities, and registration. Prior to incision, patients received both an antibiotic cefazolin (6% BBB penetrance) and levetiracetam (80% BBB penetrance), an anti-seizure drug. Subsequently, multiple blood samples and image-guided biopsies were taken and analyzed for drug concentration using liquid chromatography mass spectrometry. Biopsy drug levels are reported as Brain-Plasma Ratio (BPR), the ratio of biopsy concentration relative to plasma concentration. Mean image intensity was extracted from an 8x8 mm window surrounding each biopsy location. Regression analysis was performed to determine which combination of image types were linearly predictive of BPR for both drugs. Correlations were also analyzed according to the biopsy location radiographic appearance. RESULTS Regression analysis revealed that T2Gd intensity was linearly predictive of cefazolin BPR and FLAIR intensity was linearly predictive of levetiracetam BPR (p=0.009 and 0.041, respectively). Grouping samples according the the radiographic appearance revealed that levetiracetam BPR had a similar pattern of values to that of FLAIR intensities and cefazolin BPR had a similar pattern to T2, further supporting the regression analysis results. CONCLUSIONS Local concentrations of drug may be related to T2-weighted signals (T2Gd and T2FLAIR) rather than the gadolinium distribution on T1Gd images." @default.
- W2986155203 created "2019-11-22" @default.
- W2986155203 creator A5014011778 @default.
- W2986155203 creator A5015247761 @default.
- W2986155203 creator A5027970167 @default.
- W2986155203 creator A5036897288 @default.
- W2986155203 creator A5037781231 @default.
- W2986155203 creator A5042333597 @default.
- W2986155203 creator A5052170559 @default.
- W2986155203 creator A5052721598 @default.
- W2986155203 creator A5055522460 @default.
- W2986155203 creator A5058133357 @default.
- W2986155203 creator A5059989712 @default.
- W2986155203 creator A5087584073 @default.
- W2986155203 date "2019-11-01" @default.
- W2986155203 modified "2023-09-30" @default.
- W2986155203 title "SCIDOT-16. T2-WEIGHTED IMAGING MAY BE INDICATIVE OF DRUG DISTRIBUTION IN GLIOBLASTOMA PATIENTS" @default.
- W2986155203 doi "https://doi.org/10.1093/neuonc/noz175.1152" @default.
- W2986155203 hasPublicationYear "2019" @default.
- W2986155203 type Work @default.
- W2986155203 sameAs 2986155203 @default.
- W2986155203 citedByCount "1" @default.
- W2986155203 countsByYear W29861552032021 @default.
- W2986155203 crossrefType "journal-article" @default.
- W2986155203 hasAuthorship W2986155203A5014011778 @default.
- W2986155203 hasAuthorship W2986155203A5015247761 @default.
- W2986155203 hasAuthorship W2986155203A5027970167 @default.
- W2986155203 hasAuthorship W2986155203A5036897288 @default.
- W2986155203 hasAuthorship W2986155203A5037781231 @default.
- W2986155203 hasAuthorship W2986155203A5042333597 @default.
- W2986155203 hasAuthorship W2986155203A5052170559 @default.
- W2986155203 hasAuthorship W2986155203A5052721598 @default.
- W2986155203 hasAuthorship W2986155203A5055522460 @default.
- W2986155203 hasAuthorship W2986155203A5058133357 @default.
- W2986155203 hasAuthorship W2986155203A5059989712 @default.
- W2986155203 hasAuthorship W2986155203A5087584073 @default.
- W2986155203 hasBestOaLocation W29861552031 @default.
- W2986155203 hasConcept C101070640 @default.
- W2986155203 hasConcept C126838900 @default.
- W2986155203 hasConcept C142724271 @default.
- W2986155203 hasConcept C143409427 @default.
- W2986155203 hasConcept C2775934546 @default.
- W2986155203 hasConcept C2776429142 @default.
- W2986155203 hasConcept C2989005 @default.
- W2986155203 hasConcept C71924100 @default.
- W2986155203 hasConceptScore W2986155203C101070640 @default.
- W2986155203 hasConceptScore W2986155203C126838900 @default.
- W2986155203 hasConceptScore W2986155203C142724271 @default.
- W2986155203 hasConceptScore W2986155203C143409427 @default.
- W2986155203 hasConceptScore W2986155203C2775934546 @default.
- W2986155203 hasConceptScore W2986155203C2776429142 @default.
- W2986155203 hasConceptScore W2986155203C2989005 @default.
- W2986155203 hasConceptScore W2986155203C71924100 @default.
- W2986155203 hasLocation W29861552031 @default.
- W2986155203 hasLocation W29861552032 @default.
- W2986155203 hasOpenAccess W2986155203 @default.
- W2986155203 hasPrimaryLocation W29861552031 @default.
- W2986155203 hasRelatedWork W11452347 @default.
- W2986155203 hasRelatedWork W15570044 @default.
- W2986155203 hasRelatedWork W20450376 @default.
- W2986155203 hasRelatedWork W20820324 @default.
- W2986155203 hasRelatedWork W21873589 @default.
- W2986155203 hasRelatedWork W3476923 @default.
- W2986155203 hasRelatedWork W3582852 @default.
- W2986155203 hasRelatedWork W3780885 @default.
- W2986155203 hasRelatedWork W5521571 @default.
- W2986155203 hasRelatedWork W74385 @default.
- W2986155203 isParatext "false" @default.
- W2986155203 isRetracted "false" @default.
- W2986155203 magId "2986155203" @default.
- W2986155203 workType "article" @default.